A Rare Disease Leading to Hypertension

Abstract

HomeHypertensionVol. 79, No. 6A Rare Disease Leading to Hypertension No AccessCase ReportRequest AccessFull TextAboutView Full TextView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toNo AccessCase ReportRequest AccessFull TextA Rare Disease Leading to Hypertension Jing Chen, Xin Chen, Anna F. Dominiczak, Robert M. Carey, Cheryl L. Laffer, Fernando Elijovich, Sandra J. Taler, Tanja Dudenbostel, Rhian M. Touyz and Ji-Guang Wang Jing ChenJing Chen Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., X.C.). Search for more papers by this author , Xin ChenXin Chen https://orcid.org/0000-0002-7970-6991 Department of Cardiovascular Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.C., X.C.). Search for more papers by this author , Anna F. DominiczakAnna F. Dominiczak https://orcid.org/0000-0003-4913-3608 BHF Glasgow Cardiovascular Research Centre, Institute of Cardiovascular and Medical Sciences, University of Glasgow, Scotland, United Kingdom (A.F.D.). Search for more papers by this author , Robert M. CareyRobert M. Carey https://orcid.org/0000-0001-7238-7396 Division of Endocrinology and Metabolism, Department of Medicine, University of Virginia Health System, Charlottesville (R.M.C.). Search for more papers by this author , Cheryl L. LafferCheryl L. Laffer https://orcid.org/0000-0002-6453-6010 Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.L.L., F.E.). Search for more papers by this author , Fernando ElijovichFernando Elijovich https://orcid.org/0000-0002-2511-056X Division of Clinical Pharmacology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN (C.L.L., F.E.). Search for more papers by this author , Sandra J. TalerSandra J. Taler Division of Nephrology and Hypertension, Mayo Clinic, Rochester, MN (S.J.T.). Search for more papers by this author , Tanja DudenbostelTanja Dudenbostel https://orcid.org/0000-0003-3260-8363 Vascular Biology and Hypertension Program, Division of Cardiovascular Disease, Department of Medicine, University of Alabama, Birmingham (T.D.). Search for more papers by this author , Rhian M. TouyzRhian M. Touyz https://orcid.org/0000-0003-0670-0887 Research Institute of the McGill University Health Centre, McGill University, Montreal, Canada (R.M.T.). Search for more papers by this author and Ji-Guang WangJi-Guang Wang Correspondence to: Ji-Guang Wang, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Rd, Shanghai 200025, China. Email E-mail Address: [email protected] https://orcid.org/0000-0001-8511-1524 Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, China (J.-G.W.). Search for more papers by this author Originally published18 Mar 2022https://doi.org/10.1161/HYPERTENSIONAHA.122.18678Hypertension. 2022;79:1147–1152FootnotesThe opinions expressed in this article are not necessarily those of the editors or of the American Heart Association.Presented in part at the Clinical-Pathological Conference chaired by Anna F. Dominiczak and Rhian Touyz at the virtual Hypertension Scientific Sessions 2021, September 28, 2021. Jing Chen, Xin Chen, and Ji-Guang Wang presented the case and led the discussion.For Sources of Funding and Disclosures, see page 1151.Correspondence to: Ji-Guang Wang, Shanghai Institute of Hypertension, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, No. 197 Ruijin 2nd Rd, Shanghai 200025, China. Email [email protected]com.cn